Blood, Haemostasis and the Cardiovascular System
Blood composition, haemopoiesis, ABO and Rh groups, coagulation, cardiac action potentials, ECG, cardiac cycle and blood pressure regulation for CSIR NET.
- 25 min
On this page · 17 sections
Prerequisites
- Membranes, Transport and Electrical Properties — Nernst potentials, ion channels and pumps; cardiac action potentials are built from these.
- Protein Structure, Conformation and Stability — haemoglobin quaternary structure and allostery, used again on the respiration page.
- Enzymes: Catalysis, Kinetics, Regulation and Isozymes — the clotting cascade is a chain of zymogen activations.
The Hook: Two Drops on a Tile
How CSIR NET asks it. Part B: sites and growth factors of haemopoiesis, blood group genetics, which clotting factor is missing in a disease, ECG waves and intervals, phases of the cardiac cycle, baroreceptor wiring. Part C: compatibility tables, PT/aPTT data, ECG strips with numbers, Fick and Poiseuille calculations, pressure–volume loops and drug or lesion experiments on blood pressure.
Blood: Composition and Functions
Blood is a connective tissue with a fluid matrix. Total volume is about 7–8% of body weight (about 5 L in a 70 kg adult).
| Component | Share / value | Notes |
|---|---|---|
| Plasma | about 55% of volume | 90%+ water; proteins about 7 g/dL |
| Albumin | largest protein fraction (about 60%) | Made in liver; main source of plasma oncotic pressure; carries bilirubin, fatty acids, drugs |
| Globulins | α, β, γ | Transport proteins (transferrin, ceruloplasmin), antibodies (γ) |
| Fibrinogen | small fraction | Clotting; serum = plasma minus fibrinogen and consumed clotting factors |
| Formed elements | about 45% (haematocrit) | Haematocrit roughly 42% in men, 38% in women |
| Erythrocytes | about 5 million/µL (men), 4.5 million/µL (women) | Biconcave, no nucleus or mitochondria; life about 120 days |
| Leucocytes | about 4,000–11,000/µL | Neutrophils most numerous; lymphocytes next |
| Platelets | about 1.5–4 lakh/µL | Fragments of megakaryocytes; life about 7–10 days |
Leucocyte order by abundance: Neutrophils > Lymphocytes > Monocytes > Eosinophils > Basophils (“Never Let Monkeys Eat Bananas”).
Because mature red cells lack mitochondria, they make ATP only by glycolysis; the Rapoport–Luebering shunt diverts 1,3-bisphosphoglycerate to 2,3-BPG, which lowers haemoglobin’s O₂ affinity (see the respiration page). The pentose phosphate pathway supplies NADPH to keep glutathione reduced; G6PD deficiency therefore causes haemolysis under oxidant stress.
Red cell breakdown and bilirubin
Old red cells are removed mainly by splenic macrophages. Haem → biliverdin (haem oxygenase, releasing Fe²⁺ and CO) → bilirubin (biliverdin reductase). Unconjugated bilirubin travels on albumin to the liver, is conjugated with glucuronic acid by UDP-glucuronosyltransferase, excreted in bile, and converted by gut bacteria to urobilinogen → stercobilin (stool colour) and urobilin (urine colour).
| Jaundice | Excess bilirubin | Clue |
|---|---|---|
| Pre-hepatic (haemolytic) | Unconjugated | Haemolysis; no bilirubin in urine |
| Hepatic | Both | Hepatitis; conjugation defects (Gilbert, Crigler–Najjar: unconjugated) |
| Post-hepatic (obstructive) | Conjugated | Pale stool, dark urine (conjugated bilirubin is water-soluble) |
Haemopoiesis
Sites through life: yolk sac (early embryo) → liver (and spleen) in mid-gestation → bone marrow from late fetal life onward. In adults, red marrow persists mainly in flat bones (vertebrae, sternum, ribs, pelvis) and the proximal ends of long bones.
graph TD
HSC["Haematopoietic stem cell
self-renewing, multipotent"] --> CMP["Common myeloid progenitor"]
HSC --> CLP["Common lymphoid progenitor"]
CMP --> MEP["Megakaryocyte-erythroid progenitor"]
CMP --> GMP["Granulocyte-macrophage progenitor"]
MEP --> E["Erythrocytes
EPO"]
MEP --> MK["Megakaryocytes to platelets
TPO"]
GMP --> G["Neutrophils, eosinophils, basophils
G-CSF, GM-CSF"]
GMP --> M["Monocytes to macrophages
M-CSF"]
CLP --> L["B cells, T cells, NK cells
IL-7"]| Growth factor | Main source | Main target |
|---|---|---|
| Erythropoietin (EPO) | Kidney (peritubular interstitial cells); some from liver | Erythroid progenitors (CFU-E); release is driven by hypoxia via HIF |
| Thrombopoietin (TPO) | Mainly liver | Megakaryocytes |
| G-CSF | Macrophages, endothelium, stroma | Neutrophil production; used clinically after chemotherapy |
| GM-CSF, IL-3 | T cells, stroma | Early myeloid progenitors |
| Stem cell factor (c-Kit ligand) | Marrow stroma | HSCs and early progenitors |
Erythropoiesis sequence: proerythroblast → basophilic erythroblast → polychromatic erythroblast → orthochromatic erythroblast (nucleus expelled) → reticulocyte (residual ribosomal RNA, about 1% of circulating red cells) → erythrocyte. Haemoglobin synthesis begins at the erythroblast stages.
Nutritional needs: iron (deficiency → microcytic, hypochromic anaemia), vitamin B₁₂ and folate (DNA synthesis; deficiency → megaloblastic, macrocytic anaemia), plus vitamin B₆ (haem synthesis, ALA synthase). Iron absorption and recycling are controlled by hepcidin, a liver peptide that degrades the iron exporter ferroportin.
Blood Groups
ABO system
The ABO antigens are carbohydrates on red-cell glycoproteins and glycolipids, built on the H antigen (a fucose-containing precursor made by the FUT1 fucosyltransferase).
| Gene product | Sugar added to H | Antigen |
|---|---|---|
| A transferase (Iᴬ) | N-acetylgalactosamine | A |
| B transferase (Iᴮ) | Galactose | B |
| i (non-functional) | none | O (unmodified H) |
| Group | Genotypes | Antigen on RBC | Antibodies in plasma |
|---|---|---|---|
| A | IᴬIᴬ, Iᴬi | A | anti-B |
| B | IᴮIᴮ, Iᴮi | B | anti-A |
| AB | IᴬIᴮ | A and B | none |
| O | ii | neither (H only) | anti-A and anti-B |
- Iᴬ and Iᴮ are codominant; both are dominant over i. Two AB parents cannot have an O child; A × B parents (Iᴬi × Iᴮi) can have children of all four groups.
- Anti-A and anti-B are “naturally occurring” IgM antibodies, made in infancy against similar carbohydrate epitopes on gut bacteria. IgM does not cross the placenta.
- Red-cell transfusion: O is the universal donor, AB the universal recipient. Plasma transfusion is the reverse: AB plasma suits everyone.
- Bombay phenotype (hh): no functional H fucosyltransferase, so no H, A or B antigens even if Iᴬ or Iᴮ alleles are present. The person types as O but has anti-H as well as anti-A and anti-B, so can receive blood only from another Bombay donor. Forward typing (cells) and reverse typing (serum) together, plus anti-H, reveal it.
Rh system
The clinically important antigen is RhD, a membrane protein. Rh-negative people have no natural anti-D; it forms only after exposure (transfusion or pregnancy) and is IgG, which crosses the placenta.
Haemolytic disease of the fetus and newborn (erythroblastosis fetalis): an Rh-negative mother carrying an Rh-positive fetus is sensitised at the first delivery. In a later Rh-positive pregnancy, her anti-D IgG crosses the placenta and destroys fetal red cells: anaemia, jaundice, hydrops, kernicterus. Prevention: anti-D immunoglobulin given to the mother around delivery (and antenatally) clears fetal cells before she mounts her own response. ABO incompatibility between mother and fetus partly protects, because maternal anti-A or anti-B removes fetal cells quickly.
Haemostasis
Haemostasis is stopping blood loss without blocking healthy vessels. Four overlapping steps:
- Vascular spasm — local reflex and endothelin, thromboxane A₂ from platelets.
- Platelet plug — adhesion: von Willebrand factor (vWF) bridges exposed subendothelial collagen to platelet GPIb; activation: shape change, release of ADP and thromboxane A₂, exposure of phosphatidylserine; aggregation: activated GPIIb/IIIa (integrin αIIbβ3) binds fibrinogen, linking platelets.
- Coagulation — a protease cascade that ends in a fibrin mesh.
- Clot retraction and fibrinolysis — plasmin removes the clot as the vessel heals.
The coagulation cascade
graph TD
TF["Extrinsic: tissue factor (III)
+ VIIa"] --> X["Factor X to Xa"]
XII["Intrinsic: XII to XIIa
(contact with negative surface)"] --> XI["XI to XIa"]
XI --> IX["IX to IXa"]
IX -- "with VIIIa, Ca2+, phospholipid" --> X
TF -. "also activates IX" .-> IX
X -- "with Va, Ca2+, phospholipid
(prothrombinase)" --> T["Prothrombin (II) to thrombin (IIa)"]
T --> F["Fibrinogen (I) to fibrin"]
T -. "positive feedback:
activates V, VIII, XI, XIII, platelets" .-> X
F -- "XIIIa cross-links" --> C["Stable fibrin clot"]| Factor | Name | Point to remember |
|---|---|---|
| I | Fibrinogen | Converted to fibrin by thrombin |
| II | Prothrombin | Vitamin K-dependent |
| III | Tissue factor | Initiates the extrinsic pathway in vivo |
| IV | Ca²⁺ | Removed by citrate, oxalate, EDTA (anticoagulants for collected blood) |
| V | Proaccelerin (labile factor) | Cofactor in prothrombinase; factor V Leiden resists protein C → thrombophilia |
| VII | Proconvertin | Vitamin K-dependent; shortest half-life, so PT rises first on warfarin |
| VIII | Antihaemophilic factor | Deficient in haemophilia A (X-linked); carried in plasma by vWF |
| IX | Christmas factor | Deficient in haemophilia B (X-linked); vitamin K-dependent |
| X | Stuart–Prower factor | Vitamin K-dependent; meeting point of both pathways |
| XI | Plasma thromboplastin antecedent | Deficiency causes mild bleeding |
| XII | Hageman factor | Deficiency prolongs aPTT but does not cause bleeding |
| XIII | Fibrin-stabilising factor | A transglutaminase that cross-links fibrin (Gln–Lys isopeptide bonds) |
There is no factor VI in current use.
Vitamin K is the cofactor for γ-glutamyl carboxylase, which adds a second carboxyl to Glu residues of factors II, VII, IX, X (and anticoagulant proteins C and S). The γ-carboxyglutamate (Gla) residues bind Ca²⁺ and anchor the factors to phospholipid. Warfarin blocks vitamin K epoxide reductase, so active vitamin K is not regenerated.
Modern (cell-based) view: in vivo, tissue factor–VIIa starts clotting (initiation) and makes a small amount of thrombin; this thrombin activates platelets and factors V, VIII and XI (amplification); the tenase (IXa–VIIIa) and prothrombinase (Xa–Va) complexes on platelet surfaces then produce a thrombin burst (propagation). The intrinsic/extrinsic split is a test-tube description, still useful for reading lab tests.
Natural brakes and fibrinolysis
| Brake | Action |
|---|---|
| Antithrombin (III) | Inhibits thrombin, Xa and others; heparin accelerates it many-fold |
| Protein C + protein S | Thrombin bound to endothelial thrombomodulin activates protein C, which (with S) degrades Va and VIIIa |
| TFPI | Tissue factor pathway inhibitor blocks TF–VIIa–Xa |
| Endothelial PGI₂ and NO | Inhibit platelet activation |
| Plasmin | From plasminogen by tPA, urokinase (therapeutic: tPA, streptokinase); degrades fibrin → D-dimers |
Reading clotting tests
| Test | Measures | Prolonged by |
|---|---|---|
| Prothrombin time (PT/INR) | Extrinsic + common (VII, X, V, II, I) | Warfarin, vitamin K deficiency, liver disease, factor VII deficiency |
| aPTT | Intrinsic + common (XII, XI, IX, VIII, X, V, II, I) | Haemophilia A or B, heparin, factor XII deficiency |
| Bleeding time / platelet function | Platelet plug | Thrombocytopenia, vWF deficiency, aspirin |
| Platelet count | Number | Low in thrombocytopenia |
Aspirin irreversibly acetylates cyclooxygenase, blocking thromboxane A₂ synthesis for the platelet’s lifetime (platelets cannot make new enzyme). Von Willebrand disease (autosomal) can prolong both bleeding time and aPTT, because vWF also stabilises factor VIII.
The Heart as a Pump
Conducting system and pacemaker potentials
SA node → atria → AV node (delay of roughly 0.1 s) → bundle of His → left and right bundle branches → Purkinje fibres → ventricular muscle. The AV delay lets the atria finish emptying before ventricles contract. Purkinje fibres conduct fastest, so the ventricles contract nearly together.
Rhythmic discharge rates (Guyton): SA node about 70–80/min, AV node about 40–60/min, Purkinje fibres about 15–40/min. The SA figure is the usual in-body rate; the node’s true intrinsic rate, seen after complete autonomic blockade, is higher (roughly 100/min in young adults), because resting vagal tone holds it back (see below). The fastest pacemaker sets the rhythm (overdrive suppression); if the SA node fails, the AV node takes over (nodal rhythm); in complete heart block the ventricles beat at their slow escape rate.
| Phase | SA node (pacemaker) | Ventricular muscle |
|---|---|---|
| Resting / diastolic potential | No stable rest; maximum about −55 to −60 mV | Stable about −85 to −90 mV (K⁺ through I_K1) |
| Slow diastolic depolarisation (phase 4) | Funny current I_f (HCN channels, mainly Na⁺, opened by hyperpolarisation) + T-type Ca²⁺ | None |
| Upstroke (phase 0) | L-type Ca²⁺ (slow) | Fast Na⁺ (steep) |
| Phase 1 | — | Transient outward K⁺ (I_to) |
| Plateau (phase 2) | — | L-type Ca²⁺ in balanced by K⁺ out |
| Repolarisation (phase 3) | K⁺ (delayed rectifier) | Delayed rectifier K⁺ (I_Kr, I_Ks) |
The long plateau makes the refractory period last almost as long as the contraction, so cardiac muscle cannot be tetanised: essential for a pump that must relax and refill.
Autonomic control of rate (chronotropy):
- Sympathetic (noradrenaline → β₁ → Gs → cAMP): increases I_f and L-type Ca²⁺ current → steeper phase 4 → faster rate; also faster AV conduction and stronger contraction.
- Parasympathetic (vagus, ACh → M₂ → Gi; Gβγ opens GIRK channels, I_K,ACh): hyperpolarises the node and flattens phase 4 → slower rate. At rest vagal tone dominates, which is why resting rate is below the SA node’s intrinsic rate and rises after vagal block with atropine.
Excitation–contraction coupling in cardiac muscle
Ca²⁺ entering via L-type channels (dihydropyridine receptors) during the plateau triggers Ca²⁺-induced Ca²⁺ release from the sarcoplasmic reticulum through RyR2. Relaxation needs Ca²⁺ removal: SERCA2a (inhibited by phospholamban; PKA phosphorylation of phospholamban relieves the inhibition, so β-stimulation speeds relaxation) and the Na⁺/Ca²⁺ exchanger (NCX). Digoxin inhibits Na⁺/K⁺-ATPase → intracellular Na⁺ rises → NCX removes less Ca²⁺ → stronger contraction (positive inotropy). Contrast skeletal muscle, where the voltage sensor is mechanically coupled to RyR1 and extracellular Ca²⁺ entry is not needed.
The Electrocardiogram (ECG)
The ECG records, from the body surface, the summed potential differences produced as depolarisation and repolarisation sweep through the heart.
| Wave / interval | Event | Normal (approximate) |
|---|---|---|
| P wave | Atrial depolarisation | under 0.12 s |
| PR interval | Start of P to start of QRS: atrial depolarisation + AV nodal delay | 0.12–0.20 s |
| QRS complex | Ventricular depolarisation (atrial repolarisation hidden inside) | under 0.10–0.12 s |
| ST segment | Ventricles fully depolarised (plateau); normally isoelectric | — |
| T wave | Ventricular repolarisation | Upright in most leads |
| QT interval | Total ventricular depolarisation + repolarisation | about 0.35–0.44 s, shortens as heart rate rises |
Leads. Standard limb leads I (RA → LA), II (RA → LL), III (LA → LL) form Einthoven’s triangle; by Einthoven’s law, the voltage in lead II = lead I + lead III at any instant. Augmented leads aVR, aVL, aVF and six chest leads V1–V6 complete the 12-lead ECG. Normal mean QRS axis lies roughly between −30° and +90° (some texts extend to +110°).
Reading the paper. Standard speed 25 mm/s: one small (1 mm) square = 0.04 s, one large (5 mm) square = 0.20 s. Calibration 10 mm = 1 mV.
$$\text{Heart rate (per min)} = \frac{60}{\text{R–R interval (s)}} = \frac{1500}{\text{small squares between R waves}} = \frac{300}{\text{large squares}}$$| ECG finding | Interpretation |
|---|---|
| PR over 0.20 s, every P followed by QRS | First-degree AV block |
| PR lengthens beat by beat until a QRS drops | Second-degree, Mobitz I (Wenckebach) |
| Sudden dropped QRS, constant PR | Second-degree, Mobitz II |
| P waves and QRS complexes unrelated, slow ventricular rate | Third-degree (complete) block |
| Tall peaked T waves | Hyperkalaemia |
| ST elevation, later pathological Q waves | Acute myocardial infarction (transmural injury) |
| No P waves, irregularly irregular R–R | Atrial fibrillation |
The Cardiac Cycle
At 75 beats/min one cycle lasts 0.8 s: ventricular systole about 0.3 s, diastole about 0.5 s. Faster rates shorten diastole much more than systole, which limits filling and coronary perfusion (the left ventricle is perfused mainly in diastole).
| Phase | Valves | Ventricular volume | Key event |
|---|---|---|---|
| Atrial systole | AV open, semilunar closed | Rises (last part of filling) | “Atrial kick”; a wave in atrial/jugular pressure; S4 if ventricle is stiff |
| Isovolumetric contraction | All closed | Constant (EDV) | Pressure rises steeply; S1 (AV valves close) at its start |
| Ejection (rapid, reduced) | Semilunar open | Falls to ESV | Aortic pressure peaks about 120 mmHg |
| Isovolumetric relaxation | All closed | Constant (ESV) | S2 (aortic, pulmonary valves close); dicrotic notch on aortic trace |
| Filling (rapid, diastasis) | AV open | Rises | S3 with rapid filling (normal in the young, abnormal in older adults with failure) |
Typical left-ventricular numbers: EDV about 120–130 mL, ESV about 50–60 mL, stroke volume about 70 mL, ejection fraction about 55–60%. Left ventricle about 120/0–10 mmHg; aorta about 120/80; right ventricle about 25/0–5; pulmonary artery about 25/8.
graph LR
A["Mitral valve closes
(S1), EDV"] -- "isovolumetric
contraction" --> B["Aortic valve opens"]
B -- "ejection" --> C["Aortic valve closes
(S2), ESV"]
C -- "isovolumetric
relaxation" --> D["Mitral valve opens"]
D -- "filling" --> AThe pressure–volume loop traces this square: its width is stroke volume, its area is stroke work. Increased preload (more venous return) widens the loop to the right; increased afterload narrows it (higher ESV); increased contractility steepens the end-systolic pressure–volume line and lowers ESV.
Cardiac output and its control
$$\text{Cardiac output (CO)} = \text{Heart rate} \times \text{Stroke volume} \approx 70 \times 70\ \text{mL} \approx 5\ \text{L/min}$$- Frank–Starling law: within limits, the heart pumps whatever returns to it. Greater end-diastolic stretch → better overlap of actin and myosin and higher Ca²⁺ sensitivity of the myofilaments → stronger contraction.
- Contractility (inotropy) is independent of fibre length: raised by sympathetic stimulation, digoxin, high extracellular Ca²⁺; lowered by β-blockers, acidosis, hypoxia.
- Afterload: the load opposing ejection, approximated by aortic pressure; wall stress follows Laplace’s law (stress rises with pressure and radius, falls with wall thickness), which is why a dilated ventricle works at a disadvantage.
Fick principle (measuring CO from O₂ uptake):
$$\text{CO} = \frac{\dot V_{O_2}}{C_{aO_2} - C_{\bar vO_2}}$$With O₂ uptake 250 mL/min, arterial O₂ content 200 mL/L and mixed venous 150 mL/L: CO = 250/50 = 5 L/min.
Haemodynamics and Blood Pressure
Flow, resistance and vessels
$$\text{Flow } Q = \frac{\Delta P}{R}, \qquad R = \frac{8\eta L}{\pi r^4} \ \ \text{(Poiseuille)}$$- Resistance varies with 1/r⁴: halving a vessel’s radius raises resistance 16-fold. Small changes in arteriolar tone therefore control flow.
- The arterioles are the main resistance vessels (largest pressure drop); the capillaries have the largest total cross-sectional area and therefore the slowest velocity (velocity = flow / total area), ideal for exchange; the veins are capacitance vessels holding roughly two-thirds of blood volume.
- Series resistances add; parallel resistances add as reciprocals, so the systemic circulation (organs in parallel) has a lower total resistance than any single organ bed.
- Laminar flow is silent; turbulence (high velocity, low viscosity, narrowed vessel) produces murmurs and Korotkoff sounds.
Capillary exchange (Starling forces):
$$J_v = K_f\left[(P_c - P_i) - \sigma(\pi_c - \pi_i)\right]$$Hydrostatic pressure pushes fluid out at the arteriolar end; plasma oncotic pressure (mostly albumin) pulls it back; the small excess filtered is returned by lymph. Oedema follows raised capillary pressure (heart failure, venous obstruction), low plasma protein (liver disease, nephrotic syndrome, kwashiorkor), leaky capillaries (inflammation) or blocked lymphatics (filariasis).
Arterial pressure
$$\text{MAP} = \text{CO} \times \text{TPR}, \qquad \text{MAP} \approx \text{DBP} + \tfrac{1}{3}(\text{SBP} - \text{DBP})$$For 120/80 mmHg: pulse pressure 40 mmHg, MAP ≈ 93 mmHg. (The 1/3 rule holds at resting heart rates, when diastole occupies about two-thirds of the cycle.) Pulse pressure widens with stiff arteries (ageing) and large stroke volume; it narrows in heart failure and haemorrhage.
Regulation of blood pressure
graph TD
BP["Arterial pressure rises"] --> BR["Carotid sinus and aortic arch
baroreceptors fire more"]
BR -- "CN IX (carotid), CN X (aortic)" --> NTS["Nucleus tractus solitarius
(medulla)"]
NTS --> VAG["Vagal outflow up
(nucleus ambiguus, dorsal motor nucleus)"]
NTS --> CVLM["Caudal ventrolateral medulla
inhibits RVLM"]
CVLM --> SYM["Sympathetic outflow down"]
VAG --> HR["Heart rate down"]
SYM --> OUT["Rate, contractility, arteriolar
and venous tone down"]
HR --> FALL["Pressure returns toward set point"]
OUT --> FALL| Time scale | Mechanism | Key facts |
|---|---|---|
| Seconds | Baroreceptor reflex | Stretch receptors in carotid sinus (glossopharyngeal, Hering’s nerve) and aortic arch (vagus); buffer moment-to-moment changes (standing up); reset in chronic hypertension |
| Seconds | Peripheral chemoreceptor reflex | Carotid and aortic bodies respond to low PO₂, high PCO₂ and H⁺; becomes important when MAP falls below about 80 mmHg |
| Seconds | CNS ischaemic response | Brainstem ischaemia → intense sympathetic discharge; Cushing reflex (raised intracranial pressure → hypertension with reflex bradycardia) |
| Minutes–hours | Renin–angiotensin–aldosterone system | Renin from juxtaglomerular cells when renal perfusion pressure falls, macula densa senses low NaCl, or β₁ sympathetic input. Angiotensinogen (liver) → Ang I → ACE (mainly lung endothelium) → Ang II (AT₁): arteriolar constriction, aldosterone release, ADH release, thirst, proximal Na⁺ reabsorption |
| Minutes–hours | ADH (vasopressin) | V₁ receptors (Gq) constrict arterioles; V₂ (Gs) conserve water in collecting ducts |
| Minutes–hours | Natriuretic peptides (ANP, BNP) | From stretched atria (ANP) and ventricles (BNP); receptor guanylyl cyclase → cGMP; natriuresis, vasodilation, inhibit renin and aldosterone |
| Days | Pressure natriuresis (renal body-fluid mechanism) | Raised pressure increases Na⁺ and water excretion until volume and pressure fall; the dominant long-term set-point controller in Guyton’s model |
| Local | Autoregulation and endothelium | Myogenic response; metabolites (adenosine, CO₂, H⁺, K⁺) dilate; NO (eNOS → soluble guanylyl cyclase → cGMP), PGI₂ dilate; endothelin-1 constricts |
Drug targets that test the wiring: ACE inhibitors (also prevent bradykinin breakdown → dry cough), AT₁ receptor blockers, β₁ blockers, α₁ blockers, dihydropyridine Ca²⁺-channel blockers (arteriolar), diuretics (see the kidney section).
Memory Tricks
Don’t Confuse
| This | vs | That |
|---|---|---|
| Plasma: contains fibrinogen | vs | Serum: fluid left after clotting, lacks fibrinogen and consumed factors |
| Anti-A/anti-B: natural IgM, do not cross placenta | vs | Anti-D: immune IgG, crosses placenta |
| O: universal red-cell donor | vs | AB: universal red-cell recipient and universal plasma donor |
| Haemophilia A: factor VIII | vs | Haemophilia B: factor IX (both X-linked recessive) |
| Heparin: activates antithrombin; aPTT; works in vitro and in vivo | vs | Warfarin: vitamin K antagonist; PT/INR; works only in vivo, slow onset |
| SA node upstroke: L-type Ca²⁺ | vs | Ventricular upstroke: fast Na⁺ |
| S1: AV valves close, start of systole | vs | S2: semilunar valves close, start of diastole |
| PR interval: includes AV delay | vs | PR segment: end of P to start of QRS |
| Arterioles: largest resistance | vs | Capillaries: largest total area, slowest flow |
| Baroreceptors: pressure, fast, short-term | vs | Pressure natriuresis/RAAS: volume, slow, long-term |
Common Mistakes
Practice
All questions below are original practice questions written in CSIR NET style. They are not previous-year questions.
Level 1: Foundation
- Which organ produces most of the body’s erythropoietin?
- Which coagulation factor is a transglutaminase?
- On standard ECG paper, how long is one large square?
Answers
- Kidney (peritubular interstitial cells of the cortex).
- Factor XIII (fibrin-stabilising factor).
- 0.20 s (five small squares of 0.04 s at 25 mm/s).
Level 2: Part B Style
Q1 (practice). A woman of blood group A (whose mother was group O) has a child with a man of group AB. Which blood group is impossible for their child?
- (a) A
- (b) B
- (c) AB
- (d) O
Answer and explanation
(d) O. The woman must be Iᴬi (she received i from her O mother). The man is IᴬIᴮ and gives either Iᴬ or Iᴮ, never i. Children: IᴬIᴬ or Iᴬi (A), IᴬIᴮ (AB), Iᴮi (B). No child can be ii.
Q2 (practice). A patient has a prolonged aPTT, normal PT, normal platelet count and normal bleeding time. He has had bleeding into joints since childhood; his maternal uncle had the same problem. The most likely deficiency is:
- (a) Factor VII
- (b) Factor VIII
- (c) Von Willebrand factor
- (d) Vitamin K
Answer and explanation
(b) Factor VIII (haemophilia A). Isolated aPTT prolongation points to the intrinsic pathway (VIII, IX, XI, XII); joint bleeds and X-linked inheritance through the mother’s side fit haemophilia. Factor VII or vitamin K deficiency would prolong PT; vWF deficiency would usually prolong bleeding time as well. (Haemophilia B, factor IX, would look the same on these tests; it was not offered.)
Q3 (practice). In a resting subject with blood pressure 126/84 mmHg, the mean arterial pressure is approximately:
- (a) 98 mmHg
- (b) 105 mmHg
- (c) 112 mmHg
- (d) 84 mmHg
Answer and explanation
(a) 98 mmHg. MAP ≈ DBP + (SBP − DBP)/3 = 84 + 42/3 = 84 + 14 = 98 mmHg.
Q4 (practice). Atropine given to a healthy resting adult raises the heart rate. This shows that:
- (a) sympathetic tone to the SA node is high at rest
- (b) the SA node’s intrinsic rate is lower than the resting rate
- (c) resting vagal tone slows the SA node below its intrinsic rate
- (d) atropine opens HCN channels directly
Answer and explanation
(c). Atropine blocks muscarinic (M₂) receptors. Removing ACh action closes the GIRK current and steepens phase 4, so the node returns toward its higher intrinsic rate. The rise proves that vagal tone was restraining the rate.
Level 3: Part C Style
Q1 (practice). A subject at rest has: O₂ uptake 280 mL/min; arterial O₂ content 19.5 mL/dL; mixed venous O₂ content 15.5 mL/dL; heart rate 70/min; left-ventricular end-diastolic volume 140 mL.
(i) Calculate cardiac output. (ii) Calculate stroke volume, end-systolic volume and ejection fraction. (iii) If a drug lowers end-systolic volume by 15 mL with no change in EDV or heart rate, what is the new cardiac output?
Answer and worked solution
- A–V O₂ difference = 19.5 − 15.5 = 4.0 mL/dL = 40 mL/L. CO = 280/40 = 7.0 L/min.
- SV = CO/HR = 7000/70 = 100 mL. ESV = EDV − SV = 140 − 100 = 40 mL. EF = 100/140 = 71% (about 0.714).
- New ESV = 25 mL → SV = 115 mL → CO = 115 × 70 = 8,050 mL/min ≈ 8.05 L/min. A fall in ESV at constant EDV indicates increased contractility (positive inotropy).
Q2 (practice). An ECG recorded at 25 mm/s shows: P waves at regular intervals of 20 small squares; QRS complexes at regular intervals of 40 small squares; QRS width 3 small squares; no consistent PR interval (P waves fall at random points relative to QRS).
Which statements are correct?
(A) The atrial rate is 75/min. (B) The ventricular rate is 37.5/min. (C) The QRS duration is 0.12 s. (D) The pattern is a first-degree AV block.
- (a) A, B and C only
- (b) A and D only
- (c) B, C and D only
- (d) A, B, C and D
Answer and worked solution
(a) A, B and C only.
- Atrial rate = 1500/20 = 75/min. (A) correct.
- Ventricular rate = 1500/40 = 37.5/min. (B) correct.
- QRS = 3 × 0.04 = 0.12 s. (C) correct; a wide QRS with a rate in this range fits an escape rhythm arising below the His bundle.
- (D) wrong: in first-degree block every P is conducted with a long but constant PR. Here P and QRS are dissociated, which is third-degree (complete) AV block.
Q3 (practice). In an anaesthetised dog, both common carotid arteries are clamped below the carotid sinuses. Which statements describe the expected immediate response, and why?
(A) Carotid sinus pressure falls, so baroreceptor firing falls. (B) Sympathetic outflow rises and vagal outflow falls. (C) Systemic arterial pressure falls because less blood reaches the head. (D) Cutting both glossopharyngeal nerves before clamping would abolish most of the response.
- (a) A, B and D only
- (b) A and C only
- (c) B and C only
- (d) C and D only
Answer and worked solution
(a) A, B and D only.
- Clamping below the sinus lowers pressure in the sinus. Baroreceptors fire less (A), the NTS reduces inhibition of the RVLM and reduces vagal drive (B), so heart rate, contractility and TPR rise. Systemic pressure rises, so (C) is wrong.
- The carotid sinus nerve runs in the glossopharyngeal nerve; cutting it removes the signal (D). The aortic arch baroreceptors (vagus) remain, so a small residual response could persist, which is why “most of” is the right wording.
Quick Revision Table
| Item | Fact |
|---|---|
| Blood volume | About 7–8% of body weight; plasma about 55% |
| RBC life / platelets | 120 days / 7–10 days |
| Haemopoiesis sites | Yolk sac → liver (spleen) → marrow |
| EPO / TPO | Kidney (hypoxia, HIF) / liver |
| Anaemias | Iron → microcytic; B₁₂, folate → megaloblastic; CKD → low EPO |
| ABO | Iᴬ, Iᴮ codominant; H antigen base; anti-A/B IgM |
| Bombay | hh; no H; anti-H present |
| Rh | Anti-D IgG after sensitisation; HDFN in later pregnancy; anti-D prophylaxis |
| Platelet plug | vWF–GPIb adhesion; ADP, TXA₂; GPIIb/IIIa–fibrinogen aggregation |
| Vitamin K factors | II, VII, IX, X, proteins C and S; warfarin |
| Haemophilia | A = VIII, B = IX; X-linked; aPTT long |
| Brakes | Antithrombin (heparin), protein C/S, TFPI, plasmin (tPA) |
| Pacemaker | SA 70–80, AV 40–60, Purkinje 15–40 per min (SA intrinsic rate after full autonomic block about 100) |
| SA node | I_f (HCN) + T-type Ca²⁺ → L-type Ca²⁺ upstroke |
| Ventricle AP | Na⁺ upstroke; Ca²⁺ plateau; long refractory → no tetanus |
| ECG | PR 0.12–0.20 s; QRS under 0.12 s; II = I + III |
| Rate | 1500/small squares; 300/large squares |
| Cycle | 0.8 s at 75/min; S1 AV close, S2 semilunar close |
| LV values | EDV 120–130, ESV 50–60, SV 70 mL, EF 55–60% |
| Fick | CO = VO₂ / (CaO₂ − CvO₂) |
| Poiseuille | R ∝ 1/r⁴ |
| MAP | DBP + PP/3; MAP = CO × TPR |
| Short-term BP | Baroreceptors (IX carotid, X aortic) → NTS |
| Long-term BP | RAAS, ADH, ANP, pressure natriuresis |
Key Takeaways
What’s Next
- Respiratory and Renal Physiology — haemoglobin, gas exchange, the nephron and acid–base balance.
- Nervous System and Sense Organs — the autonomic outflow that controls the heart in detail.
- Bioenergetics and Metabolism — red-cell glycolysis and the pentose phosphate pathway.
- Quick Revision — the whole unit on one page.